Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Marksans Pharma Limited ( (IN:MARKSANS) ) has issued an announcement.
Marksans Pharma Limited has announced its unaudited financial results for the quarter and half year ending September 30, 2025, which were approved by the Board of Directors. The results, reviewed by the statutory auditors with an unmodified opinion, reflect the company’s ongoing financial performance and are available on their website, indicating transparency and compliance with regulatory standards.
More about Marksans Pharma Limited
Marksans Pharma Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of generic pharmaceutical formulations. The company serves various markets globally, providing a range of products aimed at improving health and wellness.
Average Trading Volume: 94,593
Technical Sentiment Signal: Hold
Current Market Cap: 89.09B INR
For detailed information about MARKSANS stock, go to TipRanks’ Stock Analysis page.